Obesity drug hype is finally subsiding, according to buzz metrics I follow, but too many in the media have failed to address critical issues of weight loss drugs. From my research HCPs are finally starting to ask hard questions about the use of these drugs.
Obesity drugs
The obesity market is expected to grow into a $54B market, but many questions remain, including the cost of $1,000-$1,500 a month and side effects, including nausea or diarrhea. After years of failed drugs, a new class of weight loss drugs reached the market last year — proving to be highly effective, but we don’t know about long-term side effects.